Orient Europharma Co (ROCO:4120) COGS-to-Revenue : 0.54 (As of Sep. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Orient Europharma Co COGS-to-Revenue?

Orient Europharma Co's Cost of Goods Sold for the three months ended in Sep. 2024 was NT$581 Mil. Its Revenue for the three months ended in Sep. 2024 was NT$1,067 Mil.

Orient Europharma Co's COGS to Revenue for the three months ended in Sep. 2024 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Orient Europharma Co's Gross Margin % for the three months ended in Sep. 2024 was 45.59%.

Orient Europharma Co COGS-to-Revenue Historical Data

The historical data trend for Orient Europharma Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Europharma Co COGS-to-Revenue Chart

Orient Europharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.54

0.55

0.57

0.53

Orient Europharma Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															0.51	0.49	0.52	0.51	0.54

Orient Europharma Co COGS-to-Revenue Calculation

Orient Europharma Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2444.674	/	4591.894
	=	0.53

Orient Europharma Co's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	580.581	/	1067.138
	=	0.54

Orient Europharma Co (ROCO:4120) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Orient Europharma Co's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	580.581 / 1067.138
	=	45.59 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Orient Europharma Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orient Europharma Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Orient Europharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Europharma Co Ltd (ROCO:4120) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

13th Floor, No. 128, Chengde Rd., Section 6, Beitou Distrit, Taipei, TWN, 112052

Website

https://www.oepgroup.com

Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.

Orient Europharma Co Headlines

No Headlines